{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:31Z","timestamp":1788872431223,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministerio de Ciencia e Innovaci\u00f3n; Instituto de Salud Carlos III\u2013Fondo de Investigaciones Sanitarias","award":["FIS PI\/052210, PS09\/00976 and PS09\/00551"],"award-info":[{"award-number":["FIS PI\/052210, PS09\/00976 and PS09\/00551"]}]},{"name":"Generalitat Valenciana\u2013Conselleria de Sanitat","award":["AP-084\/09"],"award-info":[{"award-number":["AP-084\/09"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jneuroim.2012.03.013","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T02:57:51Z","timestamp":1334113071000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis"],"prefix":"10.1016","volume":"247","author":[{"given":"Eduardo","family":"Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Coret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sim\u00f3-Castell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Bosc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Carlos","family":"P\u00e9rez-Miralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Burgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.03.013_bb0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0165-5728(97)00074-X","article-title":"High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis","volume":"77","author":"Annunziata","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2012.03.013_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00415-006-0185-0","article-title":"Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis","volume":"254","author":"Bartos","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0125","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1177\/35.12.3680931","article-title":"Use of cytofluorometry to evaluate binding of antibodies to the cytoskeleton of cultured cells","volume":"35","author":"Bell","year":"1987","journal-title":"J. Histochem. Cytochem."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2012.03.013_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneuroim.2010.05.032","article-title":"The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands","volume":"226","author":"Bosc\u00e1","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.35.2.212","article-title":"Oligoclonal bands in multiple sclerosis: clinicopathologic correlation","volume":"35","author":"Farrell","year":"1985","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.jneuroim.2012.03.013_bb0015","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/brain\/120.8.1461","article-title":"The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion","volume":"120","author":"Gay","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0145","first-page":"17","article-title":"Anti-GFAP antibodies in the cerebrospinal fluid of patients with multiple sclerosis and other neurologic diseases","volume":"24","author":"Gorny","year":"1990","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/intimm\/6.3.355","article-title":"Immunofluorescence analysis of B-1 cell ontogeny in the mouse","volume":"6","author":"Hamilton","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0065-2776(08)60512-X","article-title":"CD5 B cells, a fetal B cell lineage","volume":"55","author":"Hardy","year":"1994","journal-title":"Adv. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2012.03.013_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2011.09.015","volume":"313","author":"Hasan","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.18.1.709","article-title":"Regulation of antibody responses via antibodies, complement, and Fc receptors","volume":"18","author":"Heymanb","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.iy.11.040193.002441","article-title":"Origin of murine B cell lineages","volume":"11","author":"Kantor","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2012.03.013_bb0050","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1515\/CCLM.2009.313","article-title":"Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous System diseases","volume":"47","author":"Langkamp","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2012.03.013_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00234-011-0841-7","article-title":"Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes","volume":"54","author":"Magraner","year":"2012","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0120","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1460-9568.1995.tb01036.x","article-title":"Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures","volume":"7","author":"Marcaida","year":"1995","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.jneuroim.2012.03.013_bb0195","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1212\/01.wnl.0000198253.35119.83","article-title":"Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS","volume":"66","author":"Masjuan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0150","first-page":"379","article-title":"Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a","volume":"5","author":"Mata","year":"1999","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.jneuroim.2012.03.013_bb0180","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.175.9.6143","article-title":"Innate immunity and human B cell clonal expansion: effects on the recirculating B2 subpopulation","volume":"175","author":"Mongini","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02668096","article-title":"Java-b ased graphical user interface for the MRUI quantitation package","volume":"12","author":"Naressi","year":"2001","journal-title":"MAGMA"},{"issue":"6","key":"10.1016\/j.jneuroim.2012.03.013_bb0200","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1714","article-title":"Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis","volume":"14","author":"Obermeier","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ana.410270207","article-title":"Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis","volume":"27","author":"Olsson","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0170","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jnnp.2005.086116","article-title":"Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis","volume":"77","author":"Perini","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0100","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\"","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0080","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/01.wnl.0000345662.05861.e4","article-title":"Human natural autoantibodies in the treatment of neurologic disease","volume":"72","author":"Rodriguez","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2012.03.013_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jnr.10448","article-title":"Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies","volume":"71","author":"Rosenbluth","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jim.2003.09.018","article-title":"An ultrasensitive method for the detection of oligoclonalIgG bands","volume":"284","author":"S\u00e1daba","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0135","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00004728-200105000-00022","article-title":"Normalized accurate measurement of longitudinal brain change","volume":"25","author":"Smith","year":"2001","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2012.03.013_bb0035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1177\/1352458508095729","article-title":"Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis","volume":"14","author":"Thangarajh","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-1759(01)00492-6","article-title":"A sensitiveand reproducible method for the detection of oligoclonalIgM bands","volume":"258","author":"Villar","year":"2001","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.jneuroim.2012.03.013_bb0165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.59.4.555","article-title":"Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS","volume":"59","author":"Villar","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2012.03.013_bb0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.10441","article-title":"Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis","volume":"53","author":"Villar","year":"2003","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2012.03.013_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1172\/JCI22833","article-title":"Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS","volume":"115","author":"Villar","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.jneuroim.2012.03.013_bb0055","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1172\/JCI1983","article-title":"Dual implication of 2',3'-cyclic nucleotide 3' phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis","volume":"101","author":"Walsh","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.163.1.41","article-title":"Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis","volume":"163","author":"Walsh","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2012.03.013_bb0105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281200077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281200077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:35Z","timestamp":1759047515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281200077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S016557281200077X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}